CMPX
Compass Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.19 / 10
Netural
CMPX's fundamentals score 4.2/10, reflecting a balanced but not compelling picture. Key positives include an Interest Coverage Ratio of 15.48 (quartile 1, score 2) and Asset-MV at -0.50 (quartile 2, score 2). However, Days Sales Outstanding of 72.55 (quartile 2, score 1) raises concerns over receivable collection efficiency. Revenue growth remains robust with Total Operating Revenue YoY at 78.47% (quartile 2, score 2) and Operating Revenue YoY at 92.66% (quartile 2, score 2). Overall, the company shows growth resilience but faces working-capital challenges.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.06%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.06%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight19.29%
1M Return10.15%
Value-0.50
Score2/3
Weight19.29%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.60%
1M Return1.11%
Value78.47
Score2/3
Weight1.60%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
PB-ROE
Value1.04
Score2/3
Weight18.65%
1M Return9.14%
Value1.04
Score2/3
Weight18.65%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.62%
1M Return0.43%
Value92.66
Score2/3
Weight0.62%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.60%
1M Return1.11%
Value78.47
Score2/3
Weight1.60%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.06%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.06%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
PB-ROE
Value1.04
Score2/3
Weight18.65%
1M Return9.14%
Value1.04
Score2/3
Weight18.65%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.62%
1M Return0.43%
Value92.66
Score2/3
Weight0.62%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight19.29%
1M Return10.15%
Value-0.50
Score2/3
Weight19.29%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Is CMPX undervalued or overvalued?
- CMPX scores 4.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -30.33% ROE, 0.00% net margin, -18.70 P/E ratio, 5.53 P/B ratio, and -28.57% earnings growth, these metrics solidify its Netural investment rating.
